Join hematology medical experts as they discuss their approaches to hemato-oncology and hemostasis. The conversations explore scientific data, treatment landscapes, and patient experiences of various bleeding disorders and blood cancers incl. lymphoma, myeloma, hemophilia, von Willebrand disease and thrombosis.
This independent medical education podcast is for HCPs with the ultimate goal of improving care for their patients. For more information, visit www.cor2ed.com
All content for COR2ED - Hematology Medical Conversation is the property of COR2ED Medical Education and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join hematology medical experts as they discuss their approaches to hemato-oncology and hemostasis. The conversations explore scientific data, treatment landscapes, and patient experiences of various bleeding disorders and blood cancers incl. lymphoma, myeloma, hemophilia, von Willebrand disease and thrombosis.
This independent medical education podcast is for HCPs with the ultimate goal of improving care for their patients. For more information, visit www.cor2ed.com
Managing thrombosis: Part 3 - VTE: Optimal treatment duration
COR2ED - Hematology Medical Conversation
25 minutes 38 seconds
1 year ago
Managing thrombosis: Part 3 - VTE: Optimal treatment duration
Extended anticoagulation beyond the initial 3 months is indicated for all types of VTE, except in surgery-or trauma-VTE or in patients at high risk of bleeding. Are you up to date on the latest treatment options for VTE and their duration? Expert haematologists Prof. Dimitrios Tsakiris (University of Basel, Switzerland) and Prof. Jerzy Windyga (Institute of Haematology and Transfusion Medicine, Warsaw, Poland) engage in a discussion on this important topic.
This is the third podcast in a four-part series on thrombosis in various clinical conditions. In this podcast we focus on anti-thrombotic treatment for VTE and how long optimal treatment should be.
COR2ED - Hematology Medical Conversation
Join hematology medical experts as they discuss their approaches to hemato-oncology and hemostasis. The conversations explore scientific data, treatment landscapes, and patient experiences of various bleeding disorders and blood cancers incl. lymphoma, myeloma, hemophilia, von Willebrand disease and thrombosis.
This independent medical education podcast is for HCPs with the ultimate goal of improving care for their patients. For more information, visit www.cor2ed.com